Better ultrasound for thyroid cancer diagnosis
Part of Cancer, Hormones & metabolism clinical trials.
This study uses a special ultrasound method called contrast-enhanced ultrasound (CEUS) to see if it can improve accuracy of diagnosing thyroid cancer. If you have a thyroid nodule and have had certain tests, this trial may help doctors better understand your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a thyroid nodule that is 5 mm or larger and has solid parts seen on a regular ultrasound.
- You have had a regular ultrasound, a contrast-enhanced ultrasound, and a fine-needle aspiration biopsy for your nodule.
- You have a final diagnosis from pathology that confirms whether the nodule is benign or malignant.
- You have not had a thyroid ablation or surgery in the past.
- Your ultrasound images are of good quality.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence (AI) to look at ultrasound images and cell samples from thyroid nodules that had an unclear biopsy result. The goal is to see if AI can better tell which nodules are cancerous, helping avoid unnecessary surgery in the future.
This trial tests a procedure that uses heat to treat thyroid nodules that are not cancerous but have uncertain results from a biopsy. It may be an option for people who cannot or choose not to have surgery.
This study tests new ultrasound methods to better see the pancreas and thyroid. It includes people at high risk for pancreatic cancer, those with pancreatic cancer, those with a thyroid nodule, and healthy volunteers.
This study compares a new 3D technology to standard ultrasound for measuring thyroid nodule volume. It may help doctors better track changes in nodules over time.
This trial uses a special ultrasound with contrast dye to get a clearer picture of bladder cancer before any treatment. It aims to improve how doctors determine the stage of the cancer, which helps guide the best treatment plan.
This trial uses contrast-enhanced ultrasound (a special type of ultrasound) to see how well neck lymph nodes respond to chemotherapy and immunotherapy given before surgery for head and neck squamous cell carcinoma.
Hear when a new Thyroid Nodule trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.